New opinion of chronic renal disease:the effects of ADMA on the progress of the disease / 中国实用内科杂志
Chinese Journal of Practical Internal Medicine
;
(12)2001.
Artículo
en Chino
| WPRIM
| ID: wpr-567678
ABSTRACT
Asymmetric dimethylarginine(ADMA)is a natural L-arginine analogue that reduces the bioavailability of nitric oxide in plasma and various types of tissues,acting as an endogenous NO synthase inhibitor in vivo.ADMA is considered a common pathway mediating the adverse vascular effects of traditional and nontraditional risk factors.These preclinical findings are thought to be of major importance as ADMA predicts cardiovascular events and mortality in patients with chronic kidney disease(CKD).Also,ADMA uniformly predicts the progression of moderate and severe CKD.The present study summarizes the latest developments in this field.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio pronóstico
Idioma:
Chino
Revista:
Chinese Journal of Practical Internal Medicine
Año:
2001
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS